Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses

被引:8
|
作者
Campione, Elena [1 ]
Rivieccio, Antonia [1 ]
Shumak, Ruslana Gaeta [1 ]
Costanza, Gaetana [2 ]
Cosio, Terenzio [1 ,2 ]
Lambiase, Sara [1 ]
Garofalo, Virginia [1 ]
Artosi, Fabio [1 ]
Lozzi, Flavia [1 ]
Freni, Claudia [3 ]
Romeo, Alice [3 ]
Dika, Emi [4 ]
Falconi, Mattia [3 ]
Bianchi, Luca [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Syst Med, Dermatol Unit, I-00133 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med, I-00133 Rome, Italy
[3] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy
[4] Univ Bologna, Oncol Dermatol Unit, IRCCS Azienda Osped Univ Bologna, DIMEC, I-40126 Bologna, Italy
关键词
tirbanibulin; actinic keratosis; field of cancerization; SQUAMOUS-CELL CARCINOMA; PIROXICAM; 0.8-PERCENT; IMMUNE-RESPONSE; SKIN; GUIDELINES; MANAGEMENT; INSIGHTS; CARE;
D O I
10.3390/ph16121686
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Actinic keratosis is a common precancerous skin lesion that can progress into invasive squamous cell carcinomas. Many topical treatments for actinic keratoses often have poor tolerability and prolonged duration. Tirbanibulin is a novel synthetic drug with potent antitumor and antiproliferative activities. Methods: We conducted a single-center, prospective and observational study using tirbanibulin ointment on a 25 cm2 area for 5 consecutive days on 30 participants with AKs on the face or scalp. They were followed for at least 57 days to assess the safety profile and efficacy of the drug as well as treatment satisfaction. We evaluated six signs of local skin reaction (LSR): erythema, scaling, crusting, swelling, blisters/pustules, and erosions/ulcerations, grading the severity as mild, moderate, or severe. The effectiveness was evaluated both clinically and dermoscopically. The treatment satisfaction was assessed using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Results: On day 57, 70% of the patients showed a complete clinical and dermoscopic response. The highest scores obtained from the TSQM 1.4 were more evident in the convenience and side effects domains. Most LSRs, including erythema (83.3%), scaling (30%), and swelling (3.3%), occurred on day 8 but resolved spontaneously. Conclusion: Tirbanibulin is a viable therapeutic option with a short regimen treatment and good tolerability, which favors therapy adherence.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] A Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of 3.75% Imiquimod Cream Following Cryosurgery for the Treatment of Actinic Keratoses
    Jorizzo, Joseph L.
    Markowitz, Orit
    Lebwohl, Mark G.
    Bourcier, Marc
    Kulp, James
    Meng, Tze-Chiang
    Levy, Sharon
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (09) : 1101 - 1108
  • [42] Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial
    Wiegell, S. R.
    Petersen, B.
    Wulf, H. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (05) : 979 - 984
  • [44] Results from two randomized, multicenter, vehicle-controlled studies evaluating the efficacy and safety of methyl aminolevulinate-photodynamic therapy for the treatment of actinic keratoses
    Pariser, David
    Szeimies, Rolf-Markus
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB105 - AB105
  • [45] Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction
    Reiko Arita
    Motoko Kawashima
    Masataka Ito
    Kazuo Tsubota
    BMC Ophthalmology, 17
  • [46] Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction
    Arita, Reiko
    Kawashima, Motoko
    Ito, Masataka
    Tsubota, Kazuo
    BMC OPHTHALMOLOGY, 2017, 17
  • [47] The efficacy and safety of diclofenac 3% gel treatment of multiple actinic keratoses in organ transplant patients: A double-blind, randomized, vehicle-controlled study
    Ulrich, Claas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB107 - AB107
  • [48] Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial
    Erlendsson, Andres Mar
    Karmisholt, Katrine Elisabeth
    Haak, Christina Skovbolling
    Stender, Ida-Marie
    Haedersdal, Merete
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (04) : 709 - 715
  • [49] Efficacy and safety of date palm leaf-based ointment for treatment of cutaneous warts: A pilot clinical trial
    Ayatollahi, Azin
    Aramipour, Nima
    Sadri, Arash
    Firooz, Alireza
    Robati, Reza M.
    Fattahi, Mahsa
    Ayazi, Masoud
    Saber, Mohammad
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [50] Efficacy and safety of a 0.05 % nanoencapsulated imiquimod hydrogel for the treatment of actinic cheilitis: Drug release analysis and clinical study
    da Silva, Eduardo Liberato
    Pedraca, Erick Souza
    Salgueiro, Arthur Pias
    Gazzi, Rafaela Pletsch
    Nunes, Julia Silveira
    Cavagni, Juliano
    Martins, Marco Antonio Trevizani
    Rados, Pantelis Varvaki
    Pohlmann, Adriana Raffin
    Guterres, Silvia Staniscuaski
    Frank, Luiza Abrahao
    Visioli, Fernanda
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2024, 62